重楼皂苷Ⅰ通过p53信号通路诱导慢性粒细胞白血病细胞铁死亡

来源期刊：广州医药 | 605-615 发布时间：2025-06-17 收稿时间：2025/11/13 18:53:33 阅读量：23

作者：: 陈冠君,

李建厂,

孙维梅,

周明轩,

尼坤洋,

王浩,

关键词：: 重楼皂苷Ⅰ p53信号通路铁死亡 K562细胞; polyphyllin I p53 signaling pathways ferroptosis K562 cells

DOI：: 10.20223/j.cnki.1000-8535.2025.05.005

收稿时间：: 2024-03-11
修订日期：
接收日期：
引用总数：: 0

目的探讨重楼皂苷Ⅰ（PPI）对慢性髓系白血病细胞（K562）细胞的抑制作用及可能的作用机制。方法采用CCK-8法筛选药物最适浓度,将培养时间为24 h的药物最适浓度作为后续实验的干预浓度。分组如下：（1）空白组;（2）PPI组;（3）抑制剂组;（4）PPI+抑制剂组。采用CCK-8法检测细胞增殖率;AO/EB染色观察细胞形态;流式细胞术检测凋亡率;ROS检测试剂盒检测活性氧（ROS）含量、还原型谷胱甘肽含量检测试剂盒检测谷胱甘肽（GSH）含量、细胞亚铁比色法测试盒检测细胞亚铁（Fe²⁺）含量;qRT-PCR法和蛋白免疫印迹法检测各组肿瘤蛋白53（p53）、钠氯离子依赖性氨基酸转运蛋白11（SLC7A11）、谷胱甘肽过氧化物酶4（GPX4）mRNA及蛋白表达量。结果 PPI抑制K562细胞的生长,且呈一定的剂量及时间依赖性（与同时间段的对照组0μmol/L比较,均P<0.01）。与空白组相比,PPI抑制K562细胞的增殖,提高了凋亡率,而铁死亡抑制剂（Ferrostian-1）的使用逆转了PPI对K562凋亡的促进作用（P<0.01）。与空白组相比,PPI组ROS、Fe²⁺含量升高,GSH含量下降,而铁死亡抑制剂的使用可下调ROS、Fe²⁺,上调GSH的含量（P<0.01）。PPI组较空白组p53 mRNA和蛋白表达水平升高,而SLC7A11、GPX4 mRNA和蛋白表达水平下降（P<0.05）;PPI+抑制剂组细胞较重楼皂苷组p53 mRNA和蛋白表达水平下降,而SLC7A11、GPX4 mRNA和蛋白表达水平升高（P<0.05）。结论 PPI能够有效抑制K562细胞增殖,促进K562细胞铁死亡,其分子机制可能与p53信号通路的调控有关。

Objective To investigate the inhibitory effect of polyphyllin I（PPI）on chronic myeloid leukemia cells（K562）and its possible mechanism．Methods K562 cell line was cultured in suitable environment,and the optimal concentration of the drug was screened by CCK-8 method．The optimal concentration of the drug cultured for 24 hours was used as the intervention concentration of the follow-up experiment．Cells were divided into the following groups：（1）blank group,（2）saponins group,（3）inhibitor group and（4）saponins + inhibitor group．The cell proliferation rate was detected by CCK-8 method．The cell morphology was observed by AO/EB staining．The apoptosis rate was detected by flow cytometry．The contents of reactive oxygen species（ROS）,glutathione（GSH）and ferrous（Fe²⁺）in different groups were detected,and the expression of mRNA and protein in different groups were detected by qRT- PCR and Western blot respectively．Results PPI significantly inhibited the growth of K562 cells in a dose-and time-dependent manner．Compared with the blank group,PPI significantly inhibited the proliferation of K562 cells and increased the apoptosis rate of K562 cells,while the use of ferroptosis inhibitor（Ferrostian-1）reversed the promoting effect of PPI on apoptosis of K562 cells．Compared with the blank group,the contents of reactive oxygen species（ROS）and ferrous iron（Fe²⁺）increased and the content of glutathione（GSH）decreased in the saponins group．The use of Ferrostian-1 could down-regulate the contents of ROS and Fe²⁺ and increase the content of GSH in the cells treated with the drug．Compared with the blank group,the expression of p53 mRNA and protein in the saponins group increased,while the expression of SLC7A11,GPX4 mRNA and protein decreased．The expression of p53 mRNA and protein in the saponins + inhibitor group was lower than that in the saponins group,while the expression levels of SLC7A11,GPX4 mRNA and protein increased．Conclusions PPI can effectively inhibit the proliferation of K562 cells and promote ferroptosis in K562 cells．The molecular mechanism can be related to the regulation of p53 signal pathway．

1、 LI Z,FAN Q,CHEN M,et al.The interaction between polyphyllin I and SQLE protein induces hepatotoxicity through SREBP-2/HMGCR/SQLE/LSS pathway[J].J Pharm Anal,2023,13(1):39-54.

2、 WANG W,DONG X,YOU L,et al.Apoptosis in Heparg and HL-7702 cells inducted by polyphyllin II through caspases activation and cell-cycle arrest[J].J Cell Physiol,2019,234(5):7078-7089.

3、 LIU Z,GAO W,MAN S,et al.Pharmacological evaluation of sedative-hypnotic activity and gastro-intestinal toxicity of Rhizoma Paridis saponins[J].J Ethnopharmacol,2012,144(1):67-72.

4、 HE F,ZHANG P,LIU J,et al.ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11(xCT)to block stress-related ferroptosis[J].J Hepatol,2023,79(2):362-377.

5、 GAO N,TANG A L,LIU X Y,et al.P53-Dependent ferroptosis pathways in sepsis[J].Int Immunopharmacol,2023(118):110083.

6、 HU J,CAO J,TOPATANA W,et al.Targeting mutant p53 for cancer therapy:Direct and indirect strategies[J].J Hematol Oncol,2021,14(1):157.

7、 HASSIN O,OREN M.Drugging p53 in cancer:One protein,many targets[J].Nat Rev Drug Discov,2023,22(2):127-144.

8、 LIU T,JIANG L,TAVANA O,et al.The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11[J].Cancer Res,2019,79(8):1913-1924.

9、 KOPPULA P,ZHUANG L,GAN B.Cystine transporter SLC7A11/xCT in cancer:Ferroptosis,nutrient dependency,and cancer therapy[J].Protein Cell,2021,12(8):599-620.

10、 MIAO Y,CHEN Y,XUE F,et al.Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression[J].EBioMedicine,2022(76):103847.

11、 CHEN J,ZHAO F,YANG H,et al.Gentian violet induces apoptosis and ferroptosis via modulating p53 and MDM2 in hepatocellular carcinoma[J].Am J Cancer Res,2022,12(7):3357-3372.

12、 XU Y,LI Y,LI J,et al.Ethyl carbamate triggers ferroptosis in liver through inhibiting GSH synthesis and suppressing Nrf2 activation[J].Redox Biol,2022(53):102349.

13、 LI J,CAO F,YIN H L,et al.Ferroptosis:Past,present and future[J].Cell Death Dis,2020,11(2):88.

14、 TIAN Y,JIA SX,SHI J,et al.Polyphyllin I induces apoptosis and autophagy via modulating JNK and mTOR pathways in human acute myeloid leukemia cells[J].Chem Biol Interact,2019(311):108793 .

15、 ZOU P,CHEN Z,HE Q,et al.Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the ERK/DNMT1ACSL4 axis[J].Prostate,2024,84(1):64-73.

16、 ZENG Y,ZHANG Z,WANG W,et al.Underlying mechanisms of apoptosis in HepG2 cells induced by polyphyllin I through Fas death and mitochondrial pathways[J].Toxicol Mech Methods,2020,30(6):397-406.

17、 ZHANG D,LIU S,LIU Z,et al.Polyphyllin I induces cell cycle arrest in prostate cancer cells via the upregulation of IL6 and P21 expression[J].Medicine(Baltimore),2019,98(44):e17743.

18、李昕,栗东海,高小明,等.重楼皂苷通过p53/SLC7A11信号轴促进三阴性乳腺癌细胞铁死亡的机制研究[J].解放军医学杂志,2023,48(1):58-63.

19、 JIANG X,STOCKWELL B R,CONRAD M.Ferroptosis:Mechanisms,biology and role in disease[J].Nat Rev Mol Cell Biol,2021,22(4):266-282.

20、 HE J,YU S,GUO C,et al.Polyphyllin I induces autophagy and cell cycle arrest via inhibiting pdk1/akt/mtor signal and downregulating cyclin B1 in human gastric carcinoma HGC-27 cells[J].Biomed Pharmacother,2019(117):109189.

21、 ZHU X,WANG K,ZHANG K,et al.Polyphyllin I induces cell cycle arrest and cell apoptosis in human retinoblastoma Y-79 cells through targeting p53[J].Anticancer Agents Med Chem,2018,18(6):875-881.

22、 ZHANG Y,HUANG P,LIU X,et al.Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis[J].J Pharmacol Sci,2018,137(3):305-312.

23、 LIANG Y,LI X,HE X,et al.Polyphyllin I induces cell cycle arrest and apoptosis in human myeloma cells via modulating β-catenin signaling pathway[J].Eur J Haematol,2016,97(4):371-378.

24、 LIU J,ZHANG Y,CHEN L,et al.Polyphyllin I induces G2/M phase arrest and apoptosis in U251 human glioma cells via mitochondrial dysfunction and the JNK signaling pathway[J].Acta Biochim Biophys Sin(Shanghai),2017,49(6):479-486.

25、 ZHENG F,WANG Y,ZHANG Q,et al.Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis[J].Front Pharmacol,2023(14):1201715 .

26、 LONG J,PI X.Polyphyllin I promoted melanoma cells autophagy and apoptosis via PI3K/akt/mTOR signaling pathway[J].Biomed Res Int,2020(2020):5149417 .

27、 LAI L,SHEN Q,WANG Y,et al.Polyphyllin I reverses the resistance of osimertinib in non-small cell lung cancer cell through regulation of PI3K/Akt signaling[J].Toxicol Appl Pharmacol,2021(419):115518 .

28、 YANG R,GAO W,WANG Z,et al.Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis[J].Phytomedicine,2024(122):155135 .

29、 TIAN Y,GONG G Y,MA L L,et al.Anti-cancer effects of polyphyllin i:An update in 5 years[J].Chem Biol Interact,2020(316):108936 .

30、 NEMKOV T,D’ALESSANDRO A,REISZ J A.Metabolic underpinnings of leukemia pathology and treatment[J].Cancer Rep(Hoboken),2019,2(2):e1139.

31、 MINCIACCHI V R,KUMAR R,KRAUSE D S.Chronic myeloid leukemia:A model disease of the past,present and future[J].Cells,2021,10(1):117.